Employee benefits are only as effective as they are communicated internally to workers. Although many large companies offer ...

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for ...

From reviewing financial stability and breadth of services to balancing technology and human touches with virtual and ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...

Nuvation Bio (NUVB) announced it has initiated an Expanded Access Program or EAP for taletrectinib in the U.S. for the treatment of patients ...

Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

NEW YORK - Nuvation Bio Inc. (NYSE:NUVB), a biopharmaceutical company focused on oncology with a market capitalization of $777 million, has launched an Expanded Access Program (EAP) in the United ...

Forge Technology at Aero India 2025, presented its latest range of unmanned aerial vehicles (UAVs), including the NETRA 5, ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

The parents of a young Newry boy living with Duchenne Muscular Dystrophy (DMD) are calling for immediate action from ...

Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus: Pittsburgh Saturday, February 8, 2025, 09:00 Hr ...